Target intelligence / Profile preview

Lipid peroxidation chain reaction (None)

Target
None
Molecular classification
Other (not a discrete molecule or protein; refers to a chemical process)
01

Overview

Lipid peroxidation chain reactions refer to the self-propagating oxidative degradation of polyunsaturated fatty acids within biological membranes. Initiated by reactive oxygen species such as hydroxyl radicals abstracting hydrogen atoms from lipids, this process generates lipid radicals that react with molecular oxygen to form lipid hydroperoxyl radicals. These then propagate further radical formation in adjacent lipids until termination occurs via antioxidant action or radical recombination. The primary products are lipid hydroperoxides and secondary breakdown products like malondialdehyde and 4-hydroxynonenal. Lipid peroxidation is implicated in cell death pathways including apoptosis and ferroptosis and contributes significantly to tissue damage observed in neurodegeneration, cancer, cardiovascular diseases, inflammation, aging processes, and acute organ injuries. While not itself considered a therapeutic target like an enzyme or receptor protein—and thus not suitable for direct pharmacological targeting—the process can be modulated indirectly through antioxidants that interrupt the chain reaction mechanism.

Other names
Lipid peroxidationlipid oxidationlipid radical chain reactionoxidative degradation of lipids
02

Mechanism of action

Antioxidants neutralize free radicals and terminate the chain reaction by donating hydrogen atoms to lipid peroxy radicals, preventing further propagation of lipid peroxidation.

03

Biological functions

Cell death (apoptosis, ferroptosis, autophagy)Oxidative damage to cell structuresSignal transduction (via reactive aldehyde products such as 4-hydroxynonenal)
04

Disease associations

Neurodegenerative diseaseCancerCardiovascular disease (e.g., atherosclerosis)InflammationAcute kidney injury
05

Safety considerations

Non-specific inhibition may disrupt normal redox signaling.
06

Interacting drugs

Antioxidants (e.g., vitamin E)
07

Biomarkers

Malondialdehyde (MDA) measured by TBARS assay4-hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Lipid peroxidation chain reaction (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid peroxidation chain reaction (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call